Impact of pravastatin on secondary prevention of coronary artery disease in normolipidemic patients: Prospective randomized trial (PCS study)

被引：0
|
作者：
Kirino, M
Sato, S
Kobayashi, T
Nakagawa, Y
Hiraoka, H
Katoh, O
Shibata, N
Awata, N
Kobayashi, T
Reiber, JHC
Zwinderman, AH
机构：
[1] Osaka Med Ctr, Osaka, Japan
[2] Osaka Univ, Sch Med, Osaka, Japan
[3] Osaka Med Coll, Osaka, Japan
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
CIRCULATION | 1998年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2807
引用
收藏
页码：534 / 534
页数：1
相关论文
共 50 条
  • [31] Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial
    Anete Kaldal
    Serena Tonstad
    Jarle Jortveit
    BMC Cardiovascular Disorders, 21
  • [32] Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial
    Kaldal, Anete
    Tonstad, Serena
    Jortveit, Jarle
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [33] Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA Study
    Collet, Jean-Philippe
    Cayla, Guillaume
    Ennezat, Pierre-Vladimir
    Leclercq, Florence
    Cuisset, Thomas
    Elhadad, Simon
    Henry, Patrick
    Belle, Loic
    Cohen, Ariel
    Silvain, Johanne
    Barthelemy, Olivier
    Beygui, Farzin
    Diallo, Abdourahmane
    Vicaut, Eric
    Montalescot, Gilles
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 254 : 36 - 42
  • [34] Stenting of Renal Artery Stenosis in Coronary Artery Disease (RAS-CAD) study: a prospective, randomized trial
    Marcantoni, Carmelita
    Zanoli, Luca
    Rastelli, Stefania
    Tripepi, Giovanni
    Matalone, Massimo
    Di Landro, Domenico
    Scandura, Salvatore
    Tamburino, Corrado
    Zoccali, Carmine
    Castellino, Pietro
    JOURNAL OF NEPHROLOGY, 2009, 22 (01) : 13 - 16
  • [35] Pravastatin promotes coronary collateral circulation in patients with coronary artery disease
    Nishikawa, H
    Miura, S
    Zhang, B
    Shimomura, H
    Arai, H
    Tsuchiya, Y
    Saku, K
    CORONARY ARTERY DISEASE, 2002, 13 (07) : 377 - 381
  • [36] The primary and secondary prevention of coronary artery disease
    Becker, Richard C.
    Meade, Thomas W.
    Berger, Peter B.
    Ezekowitz, Michael
    O'Connor, Christopher M.
    Vorchheimer, David A.
    Guyatt, Gordon H.
    Mark, Daniel B.
    Harrington, Robert A.
    CHEST, 2008, 133 (06) : 776S - 814S
  • [37] SECONDARY PREVENTION FOR CORONARY-ARTERY DISEASE
    LAROSA, JC
    CORONARY ARTERY DISEASE, 1995, 6 (06) : 445 - 446
  • [38] Canakinumab for secondary prevention of coronary artery disease
    Ortega-Paz, Luis
    Capodanno, Davide
    Angiolillo, Dominick J.
    FUTURE CARDIOLOGY, 2021, 17 (03) : 427 - 442
  • [39] Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease
    Yamashita, Shizuya
    Masuda, Daisaku
    Ohama, Tohru
    Arai, Hidenori
    Bujo, Hideaki
    Kagimura, Tatsuo
    Kita, Toru
    Matsuzaki, Masunori
    Saito, Yasushi
    Fukushima, Masanori
    Matsuzawa, Yuji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (06) : 746 - 756
  • [40] Smartphone-guided secondary prevention for patients with coronary artery disease
    Eckardt, Irina
    Buschhaus, Clara
    Nickenig, Georg
    Jansen, Felix
    JOURNAL OF REHABILITATION AND ASSISTIVE TECHNOLOGIES ENGINEERING, 2021, 8
12345